Objectives: This study aimed to evaluate the effectiveness of an empowerment-based, self-management intervention among middle-aged patients with poorly controlled type 2 diabetes.

Methods: This is a secondary data analysis of an assessor-masked, multi-center, randomized controlled trial. A total of 166 middle-aged patients with poorly controlled type 2 diabetes were randomized to either intervention or control group. Participants in the intervention group received a patient-centered self-management intervention program guided by the Empowerment Process Model with emphasis on personally-meaningful goal-setting and action-reflection dynamics. Generalized estimating equation (GEE) was used to compare the changes in glycemic control, self-management behaviors, and psychological distress over the study periods.

Results: Participants in the intervention (n= 80) and control (n= 86) groups were homogeneous at the baseline. The intervention group demonstrated a significant and clinical meaningful reduction in HbA1c value mean (SD) from baseline (10.11% [1.76]) to 3-month (9.19% [2.06]) post-intervention (p< 0.001). Participants in the intervention groups showed significant between-group differences in diet management (p= 0.001), frequency of blood glucose self-monitoring (p= 0.005), and distress level (p< 0.001) at three-month after the completion of the intervention. However, GEE showed non-significant differences on outcome parameters.

Discussion: Middle-aged patients with poor diabetes control did not benefit from the empowerment-based self-management intervention. Considering the deteriorated consequence of poor glycemic control and expected long-term trajectory of disease management, special attention should be paid to optimize the biochemical and patient-centered outcomes of middle-aged patients with poor diabetes control.

Disclosure

L. Cheng: None. J. Sit: None. Q. Xie: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.